List of Excipients in API DESVENLAFAXINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DESVENLAFAXINE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alembic Pharmaceuticals Limited | DESVENLAFAXINE | desvenlafaxine | 46708-152 | ALGINIC ACID | |
| Alembic Pharmaceuticals Limited | DESVENLAFAXINE | desvenlafaxine | 46708-152 | CELLULOSE, MICROCRYSTALLINE | |
| Alembic Pharmaceuticals Limited | DESVENLAFAXINE | desvenlafaxine | 46708-152 | CITRIC ACID MONOHYDRATE | |
| Alembic Pharmaceuticals Limited | DESVENLAFAXINE | desvenlafaxine | 46708-152 | FERRIC OXIDE RED | |
| Alembic Pharmaceuticals Limited | DESVENLAFAXINE | desvenlafaxine | 46708-152 | HYPROMELLOSE | |
| Alembic Pharmaceuticals Limited | DESVENLAFAXINE | desvenlafaxine | 46708-152 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DESVENLAFAXINE
Detailed excipient profiles for DESVENLAFAXINE
Excipient focus: ALGINIC ACID
DESVENLAFAXINE drug variants containing ALGINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | desvenlafaxine | 46708-152 |
| Sun Pharmaceutical Industries Inc | desvenlafaxine | 63304-191 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing ALGINIC ACID
Excipient focus: AMMONIA
DESVENLAFAXINE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | desvenlafaxine | 0591-4060 |
| RPK Pharmaceuticals Inc | desvenlafaxine | 53002-1801 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing AMMONIA
Excipient focus: CELLULOSE, MICROCRYSTALLINE
DESVENLAFAXINE drug variants containing CELLULOSE, MICROCRYSTALLINE
DESVENLAFAXINE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | desvenlafaxine | 68382-105 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
DESVENLAFAXINE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | desvenlafaxine | 46708-152 |
| Sun Pharmaceutical Industries Inc | desvenlafaxine | 63304-191 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: D&C RED NO. 27 ALUMINUM LAKE
DESVENLAFAXINE drug variants containing D&C RED NO. 27 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals LLC | desvenlafaxine | 70436-013 |
| Bryant Ranch Prepack | desvenlafaxine | 71335-1815 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing D&C RED NO. 27 ALUMINUM LAKE
Excipient focus: ETHYLCELLULOSE
DESVENLAFAXINE drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| IntelliPharmaCeutics Corp | desvenlafaxine | 35208-009 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C BLUE NO. 1
DESVENLAFAXINE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | desvenlafaxine | 0054-0603 |
| Bryant Ranch Prepack | desvenlafaxine | 63629-7524 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
DESVENLAFAXINE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals LLC | desvenlafaxine | 70436-013 |
| Bryant Ranch Prepack | desvenlafaxine | 71335-1815 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
DESVENLAFAXINE drug variants containing FD&C RED NO. 40
DESVENLAFAXINE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
DESVENLAFAXINE drug variants containing FD&C YELLOW NO. 6
DESVENLAFAXINE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
DESVENLAFAXINE drug variants containing FERRIC OXIDE RED
DESVENLAFAXINE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
DESVENLAFAXINE drug variants containing FERRIC OXIDE YELLOW
DESVENLAFAXINE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
DESVENLAFAXINE drug variants containing FERROSOFERRIC OXIDE
DESVENLAFAXINE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYETHYL CELLULOSE
DESVENLAFAXINE drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| IntelliPharmaCeutics Corp | desvenlafaxine | 35208-009 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
DESVENLAFAXINE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | desvenlafaxine | 68151-5295 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
DESVENLAFAXINE drug variants containing HYPROMELLOSE
DESVENLAFAXINE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
DESVENLAFAXINE drug variants containing HYPROMELLOSE 2208
DESVENLAFAXINE drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
DESVENLAFAXINE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | desvenlafaxine | 68382-105 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
DESVENLAFAXINE drug variants containing HYPROMELLOSES
DESVENLAFAXINE drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
DESVENLAFAXINE drug variants containing MAGNESIUM STEARATE
DESVENLAFAXINE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
DESVENLAFAXINE drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | desvenlafaxine | 68382-105 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYDEXTROSE
DESVENLAFAXINE drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | desvenlafaxine | 68151-5295 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOL
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 1000
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | desvenlafaxine | 0054-0603 |
| A-S Medication Solutions | desvenlafaxine | 50090-4806 |
| American Health Packaging | desvenlafaxine | 60687-607 |
| Bryant Ranch Prepack | desvenlafaxine | 63629-7524 |
| Bryant Ranch Prepack | desvenlafaxine | 71335-1700 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOL 1000
Excipient focus: POLYETHYLENE GLYCOL 3350
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | desvenlafaxine | 0591-4060 |
| RPK Pharmaceuticals Inc | desvenlafaxine | 53002-1801 |
| Slate Run Pharmaceuticals LLC | desvenlafaxine | 70436-013 |
| Bryant Ranch Prepack | desvenlafaxine | 71335-1753 |
| Bryant Ranch Prepack | desvenlafaxine | 71335-1815 |
| Direct_Rx | desvenlafaxine er | 61919-882 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | desvenlafaxine | 68382-105 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOL 6000
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | desvenlafaxine succinate | 63629-7559 |
| Preferred Pharmaceuticals Inc | desvenlafaxine succinate | 68788-7175 |
| Proficient Rx LP | desvenlafaxine succinate | 71205-586 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOL 900000
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOL 900000
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | desvenlafaxine | 51407-021 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOL 900000
Excipient focus: POLYETHYLENE GLYCOLS
DESVENLAFAXINE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | desvenlafaxine succinate | 54868-2932 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYETHYLENE OXIDE 100000
DESVENLAFAXINE drug variants containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | desvenlafaxine | 0591-4060 |
| RPK Pharmaceuticals Inc | desvenlafaxine | 53002-1801 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYETHYLENE OXIDE 100000
Excipient focus: POLYETHYLENE OXIDE 900000
DESVENLAFAXINE drug variants containing POLYETHYLENE OXIDE 900000
DESVENLAFAXINE drug variants not containing POLYETHYLENE OXIDE 900000
Excipient focus: POLYVINYL ALCOHOL
DESVENLAFAXINE drug variants containing POLYVINYL ALCOHOL
DESVENLAFAXINE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
DESVENLAFAXINE drug variants containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | desvenlafaxine | 50090-6738 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
Excipient focus: POVIDONE K30
DESVENLAFAXINE drug variants containing POVIDONE K30
DESVENLAFAXINE drug variants not containing POVIDONE K30
Excipient focus: POVIDONE K90
DESVENLAFAXINE drug variants containing POVIDONE K90
DESVENLAFAXINE drug variants not containing POVIDONE K90
Excipient focus: PROPYLENE GLYCOL
DESVENLAFAXINE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | desvenlafaxine | 0591-4060 |
| A-S Medication Solutions | desvenlafaxine | 50090-4388 |
| Golden State Medical Supply Inc | desvenlafaxine | 51407-021 |
| RPK Pharmaceuticals Inc | desvenlafaxine | 53002-1801 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
DESVENLAFAXINE drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | desvenlafaxine | 0591-4060 |
| RPK Pharmaceuticals Inc | desvenlafaxine | 53002-1801 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
DESVENLAFAXINE drug variants containing SILICON DIOXIDE
DESVENLAFAXINE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STEARYL FUMARATE
DESVENLAFAXINE drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | desvenlafaxine | 0054-0603 |
| A-S Medication Solutions | desvenlafaxine | 50090-4806 |
| American Health Packaging | desvenlafaxine | 60687-607 |
| Bryant Ranch Prepack | desvenlafaxine | 63629-7524 |
| Bryant Ranch Prepack | desvenlafaxine | 71335-1700 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STEARIC ACID
DESVENLAFAXINE drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | desvenlafaxine | 68382-105 |
| Zydus Pharmaceuticals (USA) Inc | desvenlafaxine | 68382-469 |
| Zydus Lifesciences Limited | desvenlafaxine | 70771-1311 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing STEARIC ACID
Excipient focus: TALC
DESVENLAFAXINE drug variants containing TALC
DESVENLAFAXINE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | desvenlafaxine | 68151-5295 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
DESVENLAFAXINE drug variants containing TITANIUM DIOXIDE
DESVENLAFAXINE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
DESVENLAFAXINE drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | desvenlafaxine | 68382-105 |
| Zydus Pharmaceuticals (USA) Inc | desvenlafaxine | 68382-469 |
| Zydus Lifesciences Limited | desvenlafaxine | 70771-1311 |
| >Company | >Ingredient | >NDC |
DESVENLAFAXINE drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
